Veteran cardiovascular imaging and diagnostics sales leader to drive go-to-market strategy as Elucid prepares for FDA clearance of FFR-CT BOSTON— Sept. 29, 2026 — Elucid, a medical technology company using AI-powered, clinically validated software to advance precision diagnosis of cardiovascular disease, today announced that Mark Miller has joined the company as chief revenue officer (CRO). […]